In this live and interactive CME-certified program, an expert faculty panel will discuss surveillance and ongoing screening for HCC in the hepatology setting, early identification of patients with HCC, and new management and therapeutic options for patients diagnosed with HCC.
Presented for attendees of the 59th AASLD Annual Meeting. This is not an official function/event of the American Association for the Study of Liver Diseases.
Program Director
Robert G. Gish, MD
Medical Director
Liver Transplant Program
California Pacific Medical Center
San Francisco, California
Faculty
Al B. Benson III, MD
Professor, Division of Hematology/Oncology
Feinberg School of Medicine at Northwestern University
Associate Director for Clinical Investigations
Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois
Morris Sherman, MB BCh, PhD, FRCP(C)
Associate Professor of Medicine
University of Toronto
Toronto, Ontario, Canada
Barbara Sigler Morgan, MSN, NP
Nurse Practitioner, Complex GI/Hepatology
Liver Transplant Department
Physician Foundation California Pacific Medical Center
Sacramento, California